{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:06:27Z","timestamp":1766084787586,"version":"build-2065373602"},"reference-count":62,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pomeranian Medical University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Diabetes is a common chronic disease. Untreated diabetes may lead to complications such as nephropathy, neuropathy, retinopathy, and macroangiopathies. The main goal in treating diabetes is to limit the development of vascular complications. The FGF (fibroblast growth factor) family, with its potential as a biomarker for diabetic complications, offers a promising avenue for future research and treatment. The study aimed to analyze and compare the concentrations of selected fibroblast growth factors, FGF-2, FGF-19, FGF-22, and FGF-23, in the plasma of patients with type 1 and type 2 diabetes with those of the control group. The study group consisted of 73 patients, including 33 people with type 1 diabetes (18 M and 15 W) aged 18 to 68 years and 40 with type 2 diabetes (20 M and 20 W) aged 25 to 90. The control group consisted of 41 healthy individuals (23 men and 18 women) aged 21 to 56. The FGF-2, FGF-19, FGF-22, and FGF-23 concentrations were measured using ELISA. The study observed a significant relationship between the levels of FGF19 and FGF22 in the serum of patients with type 1 and type 2 diabetes, as well as in the control group (p &lt; 0.001; p &lt; 0.001). Statistical analysis revealed a significant relationship between FGF-2 and FGF-22 concentrations and hypertension (p = 0.03; p = 0.01). A statistically significant difference was also found between the concentrations of FGF-19 and FGF-22 (p = 0.001; p &lt; 0.001) in the serum of people with normal weight and people with overweight and obesity. A significant correlation was also observed between the concentrations of FGF-22 and FGF-23 and arthritis (p = 0.01; p = 0.02). FGF-2, FGF-19, FGF-22, and FGF-23 likely significantly impact diabetes and its complications. In the future, they could serve as biomarkers for diabetic complications, aiding in diagnosis, patient monitoring, and even predicting potential complications for individuals. However, more research in this area is necessary.<\/jats:p>","DOI":"10.3390\/ijms26178754","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:27:12Z","timestamp":1757500032000},"page":"8754","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Promising Role of Selected Fibroblast Growth Factors as Potential Markers of Complications in Type 1 and Type 2 Diabetes"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7313-7193","authenticated-orcid":false,"given":"El\u017cbieta","family":"Cecerska-Hery\u0107","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ja\u015bmina","family":"Micha\u0142\u00f3w","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weronika","family":"Engwert","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Marciniak","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6256-5695","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Birger","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1769-2037","authenticated-orcid":false,"given":"Natalia","family":"Serwin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa\u0142","family":"Hery\u0107","sequence":"additional","affiliation":[{"name":"Cardiothoracic Surgery Clinic, Cardiac Rehabilitation Department, Pomeranian Medical University of Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Polikowska","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Goszka","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Wi\u015bniewska","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University of Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3138-1013","authenticated-orcid":false,"given":"Barbara","family":"Do\u0142\u0119gowska","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Pomeranian Medical University of Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1042\/CS20201290","article-title":"Phosphate and fibroblast growth factor 23 in diabetes","volume":"135","author":"Yeung","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Jin, Q., and Ma, R.C.W. (2021). Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies. Cells, 10.","DOI":"10.3390\/cells10112832"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Artasensi, A., Pedretti, A., Vistoli, G., and Fumagalli, L. (2020). Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs. Molecules, 25.","DOI":"10.3390\/molecules25081987"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023","volume":"46","author":"Nuha","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e2100275","DOI":"10.1002\/advs.202100275","article-title":"Emerging Targets in Type 2 Diabetes and Diabetic Complications","volume":"8","author":"Demir","year":"2021","journal-title":"Adv. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1210\/er.2019-00088","article-title":"Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine","volume":"40","author":"Udler","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.2147\/JIR.S334996","article-title":"The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy","volume":"14","author":"Deng","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Liu, Y., Liu, Y., Deng, J., Li, W., and Nie, X. (2021). Fibroblast Growth Factor in Diabetic Foot Ulcer: Progress and Therapeutic Prospects. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.744868"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.dsx.2019.01.048","article-title":"Association of diabetic foot ulcers with chronic vascular diabetic complications in patients with type 2 diabetes","volume":"13","author":"Megallaa","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"111617","DOI":"10.1016\/j.mce.2022.111617","article-title":"Fibroblast growth factor 15\/19 expression, regulation, and function: An overview","volume":"548","author":"Guthrie","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1517\/13543784.2015.1006357","article-title":"Fibroblast growth factor 19-targeted therapies for treating metabolic disease","volume":"24","author":"Rysz","year":"2015","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Donate-Correa, J., Mart\u00edn-N\u00fa\u00f1ez, E., Gonz\u00e1lez-Luis, A., Ferri, C.M., Luis-Rodr\u00edguez, D., Tagua, V.G., Mora-Fern\u00e1ndez, C., and Navarro-Gonz\u00e1lez, J.F. (2021). Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes. J. Clin. Med., 10.","DOI":"10.3390\/jcm10122583"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.kint.2019.05.018","article-title":"FGF23 and inflammation-a vicious coalition in CKD","volume":"96","author":"Czaya","year":"2019","journal-title":"Kidney Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.diabres.2011.05.016","article-title":"Improved Refractory Wound Healing with Administration of Acidic Fibroblast Growth Factor in Diabetic Rats","volume":"93","author":"Xie","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/wrr.12375","article-title":"Proapoptotic Effect of Control-Released Basic Fibroblast Growth Factor on Skin Wound Healing in a Diabetic Mouse Model","volume":"24","author":"Huang","year":"2016","journal-title":"Wound Repair. Regener"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/07435800.2011.558550","article-title":"Serum FGF-21 Levels in Type 2 Diabetic Patients","volume":"36","author":"Cheng","year":"2011","journal-title":"Endocr. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11892-020-01335-7","article-title":"Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: A Bitter-Sweet Symphony","volume":"20","author":"Yeung","year":"2020","journal-title":"Curr. Diab. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4239\/wjd.v15.i3.392","article-title":"Roles of fibroblast growth factors in the treating diabetes","volume":"15","author":"Zhang","year":"2024","journal-title":"World J. Diabetes"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cho, H.W., Jin, H.S., and Eom, Y.B. (2022). FGFRL1 and FGF genes are associated with height, hypertension, and osteoporosis. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0273237"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1093\/emboj\/17.15.4213","article-title":"Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice","volume":"17","author":"Dono","year":"1998","journal-title":"EMBO J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1210\/me.2005-0322","article-title":"Glycated fibroblast growth factor-2 is quickly produced in vitro upon low-millimolar glucose treatment and detected in vivo in diabetic mice","volume":"20","author":"Facchiano","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2147\/DMSO.S231735","article-title":"Role of TNF-\u03b1 and FGF-2 in the Fracture Healing Disorder of Type 2 Diabetes Model Induced by High Fat Diet Followed by Streptozotocin","volume":"13","author":"Huang","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e14787","DOI":"10.1111\/dme.14787","article-title":"Enhanced growth factor expression in chronic diabetic wounds treated by cold atmospheric plasma","volume":"39","author":"Hiller","year":"2022","journal-title":"Diabet. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/jdi.12241","article-title":"Glycated hemoglobin for diagnosing diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization","volume":"6","author":"Incani","year":"2015","journal-title":"J. Diabetes Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1165\/rcmb.2010-0317OC","article-title":"Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension","volume":"45","author":"Tu","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10735-007-9101-x","article-title":"Aortic coarctation hypertension induces fibroblast growth factor-2 immunoreactivity in the stimulated nucleus tractus solitarii","volume":"38","author":"Varella","year":"2007","journal-title":"J. Mol. Histol."},{"key":"ref_29","first-page":"390","article-title":"Fibroblast growth factor-19 levels in type 2 diabetic patients with metabolic syndrome","volume":"41","author":"Barutcuoglu","year":"2011","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.21037\/atm-20-5203","article-title":"Decreased serum fibroblast growth factor 19 level is a risk factor for type 1 diabetes","volume":"9","author":"Barutcuoglu","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/en.2003-1671","article-title":"Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/endo.143.5.8850","article-title":"Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity","volume":"143","author":"Tomlinson","year":"2002","journal-title":"Endocrinology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/joim.13767","article-title":"Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases","volume":"295","author":"Li","year":"2024","journal-title":"J. Intern. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wang, D., Zhu, W., Li, J., An, C., and Wang, Z. (2013). Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: Association with insulin resistance, adiponectin, and polycystic ovary syndrome history. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0081190"},{"key":"ref_35","first-page":"627","article-title":"Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: The influence of acute hyperinsulinemia, very-low calorie diet and PPAR-\u03b1 agonist treatment","volume":"60","author":"Trachta","year":"2011","journal-title":"Physiol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","article-title":"Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man","volume":"260","author":"Angelin","year":"2006","journal-title":"J. Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cmet.2012.11.001","article-title":"Circulating fibroblast growth factors as metabolic regulators-a critical appraisal","volume":"16","author":"Angelin","year":"2012","journal-title":"Cell Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.clnu.2016.04.027","article-title":"FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss","volume":"36","author":"Domingo","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/00365510701854967","article-title":"Fibroblast growth factor-19: Development, analytical characterization and clinical evaluation of a new ELISA test","volume":"68","author":"Stejskal","year":"2008","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.transproceed.2013.10.043","article-title":"Fibroblast growth factor-23 levels are associated with uric acid but not carotid intima media thickness in renal transplant recipients","volume":"46","author":"Asicioglu","year":"2014","journal-title":"Transplant. Proc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/cns.12760","article-title":"Fibroblast growth factor 22 is a novel modulator of depression through interleukin-1\u03b2","volume":"23","author":"Xu","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.CIR.0000116762.77804.FC","article-title":"Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction","volume":"109","author":"Chaudhuri","year":"2004","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"111615","DOI":"10.1016\/j.diabres.2024.111615","article-title":"The association between interleukin family and diabetes mellitus and its complications: An overview of systematic reviews and meta-analyses","volume":"210","author":"Jin","year":"2024","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_44","first-page":"635","article-title":"Inflammation in the pathophysiology and therapy of type 2 diabetes","volume":"19","author":"Donath","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.2174\/1381612811319320005","article-title":"Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases","volume":"19","author":"Fiorentino","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_49","first-page":"300","article-title":"Correlation Between Fibroblast Growth Factor-23 and Pulmonary Arterial Hypertension in Hemodialysis Patients","volume":"15","author":"Miri","year":"2021","journal-title":"Iran. J. Kidney Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Rodelo-Haad, C., Rodr\u00edguez-Ortiz, M.E., Martin-Malo, A., Pendon-Ruiz de Mier, M.V., Ag\u00fcera, M.L., Mu\u00f1oz-Casta\u00f1eda, J.R., Soriano, S., Caravaca, F., Alvarez-Lara, M.A., and Felsenfeld, A. (2018). Phosphate control in reducing FGF23 levels in hemodialysis patients. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0201537"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc11-2235","article-title":"Chronic Renal Insufficiency Cohort Study Group. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease","volume":"35","author":"Wahl","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1111\/j.1582-4934.2008.00678.x","article-title":"Involvement of SOX-9 and FGF-23 in RUNX-2 regulation in osteoarthritic chondrocytes","volume":"13","author":"Orfanidou","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1507\/endocrj.EJ15-0627","article-title":"Fibroblast growth factor 1 levels are elevated in newly diagnosed type 2 diabetes compared to normal glucose tolerance controls","volume":"63","author":"Wang","year":"2016","journal-title":"Endocr. J."},{"key":"ref_55","first-page":"e17723","article-title":"Fibroblast Growth Factor 21 and Its Association With Oxidative Stress and Lipid Profile in Type 2 Diabetes Mellitus","volume":"13","author":"Aleem","year":"2021","journal-title":"Cureus"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/15548627.2022.2072054","article-title":"Tubular cells produce FGF2 via autophagy after acute kidney injury leading to fibroblast activation and renal fibrosis","volume":"19","author":"Livingston","year":"2023","journal-title":"Autophagy"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"F470","DOI":"10.1152\/ajprenal.90538.2008","article-title":"FGF23-mediated regulation of systemic phosphate homeostasis: Is Klotho an essential player?","volume":"296","author":"Razzaque","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ijo.2014.76","article-title":"Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients","volume":"39","author":"Catalan","year":"2015","journal-title":"Int. J. Obes."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13098-019-0475-1","article-title":"Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients","volume":"11","author":"Tang","year":"2019","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Chen, H.-Y., Fang, W.-C., Chu, S.-C., Wang, P.-H., Lee, C.-C., Wu, I.-W., Sun, C.-Y., Hsu, H.-J., Chen, C.-Y., and Chen, Y.-C. (2023). Circulating Fibroblast Growth Factor-23 Levels Can Predict Rapid Kidney Function Decline in a Healthy Population: A Community-Based Study. Biomolecules, 13.","DOI":"10.3390\/biom13010031"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1681\/ASN.2017121334","article-title":"Fibroblast growth factor-23 and risks of cardiovascular and noncardiovascular diseases: A meta-analysis","volume":"29","author":"Marthi","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Rodelo-Haad, C., Santamaria, R., Mu\u00f1oz-Casta\u00f1eda, J.R., Pend\u00f3n-Ruiz de Mier, M.V., Martin-Malo, A., and Rodriguez, M. (2019). FGF23, biomarker or target?. Toxins, 11.","DOI":"10.3390\/toxins11030175"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8754\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:42:17Z","timestamp":1760035337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":62,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijms26178754"],"URL":"https:\/\/doi.org\/10.3390\/ijms26178754","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}